AnaptysBio, Inc. (ANAB) Tops Q1 EPS by 2c

AnaptysBio, Inc. (NASDAQ: ANAB) reported Q1 EPS of ($1.28), $0.02 better than the analyst estimate of ($1.30).

For earnings history and earnings-related data on AnaptysBio, Inc. (ANAB) click here.

You May Also Be Interested In

• Goldman Sachs (GS) Reiterated at Market Perform by Citizens on Constructive Backdrop
• Goldman Sachs Upgrades Primoris Services Corporation (PRIM) to Neutral
• Deutsche Bank Downgrades Man Group Plc. (EMG:LN) (MNGPY) to Hold